PhytoHealth Corporation (TPE:4108)
Taiwan · Delayed Price · Currency is TWD 10.90
+0.15 (1.40%)
Aug 19, 2026, 1:30 PM CST
PhytoHealth Revenue
PhytoHealth had revenue of 35.91M TWD in the quarter ending June 30, 2026, with 15.72% growth. This brings the company's revenue in the last twelve months to 143.43M, up 3.62% year-over-year. In the year 2025, PhytoHealth had annual revenue of 134.58M, down -12.36%.
Revenue (ttm)
143.43M
Revenue Growth
+3.62%
P/S Ratio
14.89
Revenue / Employee
1.71M
Employees
84
Market Cap
2.14B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 134.58M | -18.99M | -12.36% |
| Dec 31, 2024 | 153.56M | -8.93M | -5.49% |
| Dec 31, 2023 | 162.49M | 27.02M | 19.95% |
| Dec 31, 2022 | 135.47M | -33.47M | -19.81% |
| Dec 31, 2021 | 168.94M | 77.13M | 84.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Maywufa Company | 1.64B |
| TSH Biopharm Corporation | 1.40B |
| Allied Biotech | 922.49M |
| Easywell Biomedicals | 799.94M |
| GeneFerm Biotechnology | 664.94M |
| Tien Liang BioTech | 650.87M |
| Johnson Chemical Pharmaceutical Works | 569.57M |
| LIWANLI Innovation | 414.67M |